Home / Market News / $ZEAL

$ZEAL news and market catalysts

The 3 most recent market catalysts affecting $ZEAL, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

3 catalysts 2 high impact 3 bullish 0 bearish Pharmaceuticals
Nov 13, 2026 Corporate Catalyst Bullish Impact 85
Zealand Pharma Receives EU Marketing Authorization for Zeydovio (glepaglutide)
Zealand Pharma has secured EU marketing authorization for Zeydovio, a long-acting GLP-2 analog for short bowel syndrome. This is a major positive catalyst as it's the first signifi…
Nov 4, 2026 Corporate Catalyst Bullish Impact 75
ZEAL Network Reports 22% Revenue Growth for First Nine Months of 2026
ZEAL Network SE announced a 22% year-on-year revenue increase for the first nine months of 2026, reaching €198.8 million, and a 9% rise in EBITDA. This growth was fueled by its cor…
Oct 13, 2026 Corporate Catalyst Bullish Impact 95
'Zealand Pharma Makes Deal With Generate Worth Up to $1.2 Billion' - Bloomberg
Zealand Pharma has announced a deal with Generate that could be worth up to $1.2 billion. This is a highly significant event for the company, as it represents a substantial influx …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.